Medical Science Liaison

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most. Contractor Medical Science Liaison (MSL) – Italy/Germany Territory Haematology / Oncology – Phase 3 Clinical Trial Support Role Overview We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework. The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders. Territory Coverage Primary territories:
* Italy
* Germany Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required. Time in Field Approximately 70–80% field-focused activity expected.

Key Responsibilities
* Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals
* Support scientific engagement around an ongoing Phase 3 haematology clinical trial
* Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs
* Support trial awareness and operational engagement activities within assigned territories
* Identify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback
* Support congress activities, investigator meetings, and scientific discussions as required
* Ensure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements
* Work cross-functionally with Medical Affairs, Clinical Operations, and other internal stakeholders Required Qualifications & Experience
* Advanced scientific or healthcare degree (PharmD, PhD, MD, MSc or equivalent)
* Prior experience as a field-based MSL within oncology or haematology
* Strong scientific acumen and ability to communicate complex clinical data effectively
* Demonstrated ability to work independently across a multi-site territory
* Experience developing relationships with academic investigators and healthcare professionals
* Strong communication, presentation, and stakeholder engagement skills
* Experience working within GCP, pharmacovigilance, and compliance frameworks
* Experience within Italy and/or Germany is essential Strongly Preferred
* Italian language proficiency strongly preferred
* Prior experience in haematology and/or rare cancers
* Experience supporting Phase 2 or Phase 3 clinical trials
* Experience supporting recruitment or referral engagement activities for clinical trials
* Existing relationships within relevant haematology treatment centres
* Experience working in multinational European territories Working Model
* Field-based role
* Travel required across assigned territories #J-18808-Ljbffr